About
Specialty medicines
Areas of Focus
Categories
Drug Delivery DeviceSmall Molecule Pharmaceutical
Team (2)
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,862
By Phase
PHASE2/PHASE3: 1PHASE3: 4PHASE2: 2NA: 1PHASE4: 1
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05281328Lead Sponsor
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
PHASE2/PHASE3Active, not recruiting
71 participants
Started: Jun 28, 2022 · Completed: Aug 31, 2027
NCT05050942Lead Sponsor
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients with GEP-NET
PHASE3Active, not recruiting
332 participants
Started: Oct 22, 2021 · Completed: Dec 31, 2027
NCT04125836Lead Sponsor
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
PHASE3Completed
135 participants
Started: Oct 10, 2019 · Completed: Apr 24, 2025
NCT04076462Lead Sponsor
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
PHASE3Completed
72 participants
Started: Aug 19, 2019 · Completed: May 2, 2023
NCT02946073Collaborator
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
PHASE3Completed
1,053 participants
Started: Sep 30, 2016 · Completed: Feb 28, 2019
Locations (1)
Headquarters
Lund, Sweden
Map
Loading map...